Differential activation of extracellular signal regulated kinase isoforms in preconditioning and opioid-induced cardioprotection

Journal of Pharmacology and Experimental Therapeutics

Volumn 296, Issue 2, 2001, Pages 642-649

  Fryer, Ryan M ^a   Pratt, Phillip F ^a   Hsu, Anna K ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,4A,5,12,12AALPHA OCTAHYDRO 4AALPHA (3 HYDROXYPHENYL) 2 METHYLQUINOLINO[2,3 G]ISOQUINOLINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OPIATE; SIGMA 1 OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; WESTERN BLOTTING;

ANALGESICS, OPIOID; ANIMALS; BLOOD PRESSURE; BLOTTING, WESTERN; CELL NUCLEUS; COS CELLS; CYTOSOL; ENZYME ACTIVATION; ENZYME INHIBITORS; HEART DISEASES; HEART RATE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; ISOENZYMES; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 0035141233     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Protein kinase C translocation and PKC-dependent protein phosphorylation during myocardial ischemia
2. Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes
3. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death
4. βγ subunits
5. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and independent mechanisms
6. Agonist activation of p42 and p44 mitogen-activated protein kinases following expression of the mouse d opioid receptor in rat-1 fibroblasts: Effects of receptor expression levels and comparisons with G-protein activation
7. ATP
8. ATP channel in the preservation of mitochondrial function
9. ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection
10. ATP channels
11. ATP channels
12. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts
13. Opioid effects on mitogen-activated protein kinase signaling cascades
14. The mechanism of the tetrazolium reaction in identifying myocardial infarction
15. μ and δ-Opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization
16. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium
17. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion
18. An inhibitor of p38 mitogen-activated protein kinase protects neonatal cardiac myocytes from ischemia
19. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts
20. Ischemic preconditioning triggers tyrosine kinase signaling: A potential role for MAPKAP kinase 2
21. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits
22. Calcium preconditioning elicits storing protection against ischemic injury via a protein kinase C signaling pathway
23. Role of p38 MAP kinase in myocardial stress
24. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits
25. Activation of the mitogen activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes
26. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart
27. 1- but not μ- or κ-opioid receptors
28. ATP channels
29. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts
30. Glibenclamide-induced blockage of ischemic preconditioning is time dependent in intact rat heart
31. PAK, p38 mitogen-activated protein kinase (MAPK), and stress-activated protein kinase (SAPK) in cultured rat cardiac myocytes
32. Rsk1 mediates a MEK-MAP kinase cell survival signal
33. Protein kinase C: Its role in ischemic preconditioning in the rat
34. Inhibition of ER-Kinase cascade by PD 098059 and U0126 counteracts ischemic preconditioning in pig myocardium
35. "Stress Responsive" mitogen-activated protein kinases (c-jun N-terminal kinases and p38 mitogen-activated protein kinases) in the myocardium
36. Activation of mitogen-activated protein kinases in human heart during cardiopulmonary bypass
37. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart
38. Preconditioning protects ischemic rabbit heart by protein kinase C activation
39. Inhibition of extracellular signal-regulated kinase enhances ischemia/reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart
40. MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes